BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27358755)

  • 1. Poly(amido amine) dendrimers in oral delivery.
    Yellepeddi VK; Ghandehari H
    Tissue Barriers; 2016; 4(2):e1173773. PubMed ID: 27358755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery.
    Sadekar S; Ghandehari H
    Adv Drug Deliv Rev; 2012 May; 64(6):571-88. PubMed ID: 21983078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.
    Sadekar S; Thiagarajan G; Bartlett K; Hubbard D; Ray A; McGill LD; Ghandehari H
    Int J Pharm; 2013 Nov; 456(1):175-85. PubMed ID: 23933439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transepithelial Transport of PAMAM Dendrimers Across Isolated Human Intestinal Tissue.
    Hubbard D; Enda M; Bond T; Moghaddam SP; Conarton J; Scaife C; Volckmann E; Ghandehari H
    Mol Pharm; 2015 Nov; 12(11):4099-107. PubMed ID: 26414679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transepithelial and endothelial transport of poly (amidoamine) dendrimers.
    Kitchens KM; El-Sayed ME; Ghandehari H
    Adv Drug Deliv Rev; 2005 Dec; 57(15):2163-76. PubMed ID: 16289433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of surface engineered polyamidoamine (PAMAM) dendrimers across IPEC-J2 cell monolayers.
    Pisal DS; Yellepeddi VK; Kumar A; Palakurthi S
    Drug Deliv; 2008 Nov; 15(8):515-22. PubMed ID: 18720134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability.
    Kolhatkar RB; Kitchens KM; Swaan PW; Ghandehari H
    Bioconjug Chem; 2007; 18(6):2054-60. PubMed ID: 17960872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity.
    Goldberg DS; Vijayalakshmi N; Swaan PW; Ghandehari H
    J Control Release; 2011 Mar; 150(3):318-25. PubMed ID: 21115079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional Morphology and Transport of PAMAM Dendrimers Across Isolated Rat Intestinal Tissue.
    Hubbard D; Bond T; Ghandehari H
    Macromol Biosci; 2015 Dec; 15(12):1735-43. PubMed ID: 26332343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers.
    Zhong Q; Humia BV; Punjabi AR; Padilha FF; da Rocha SRP
    Eur J Pharm Sci; 2017 Nov; 109():86-95. PubMed ID: 28774811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transepithelial transport of PAMAM dendrimers across isolated rat jejunal mucosae in ussing chambers.
    Hubbard D; Ghandehari H; Brayden DJ
    Biomacromolecules; 2014 Aug; 15(8):2889-95. PubMed ID: 24992090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers.
    El-Sayed M; Ginski M; Rhodes C; Ghandehari H
    J Control Release; 2002 Jun; 81(3):355-65. PubMed ID: 12044574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers.
    Pisal DS; Yellepeddi VK; Kumar A; Kaushik RS; Hildreth MB; Guan X; Palakurthi S
    Int J Pharm; 2008 Feb; 350(1-2):113-21. PubMed ID: 17913410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charge affects the oral toxicity of poly(amidoamine) dendrimers.
    Thiagarajan G; Greish K; Ghandehari H
    Eur J Pharm Biopharm; 2013 Jun; 84(2):330-4. PubMed ID: 23419816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system.
    Ke W; Zhao Y; Huang R; Jiang C; Pei Y
    J Pharm Sci; 2008 Jun; 97(6):2208-16. PubMed ID: 17879294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transepithelial transport of PEGylated anionic poly(amidoamine) dendrimers: implications for oral drug delivery.
    Sweet DM; Kolhatkar RB; Ray A; Swaan P; Ghandehari H
    J Control Release; 2009 Aug; 138(1):78-85. PubMed ID: 19393702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.
    Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK
    Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of oral translocation of anionic G6.5 dendrimers in mice.
    Thiagarajan G; Sadekar S; Greish K; Ray A; Ghandehari H
    Mol Pharm; 2013 Mar; 10(3):988-98. PubMed ID: 23286733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative evaluation of the effect of poly(amidoamine) dendrimers on the porosity of epithelial monolayers.
    Lin YL; Khanafer K; El-Sayed ME
    Nanoscale; 2010 May; 2(5):755-62. PubMed ID: 20648321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene delivery efficiency and cytotoxicity of heterocyclic amine-modified PAMAM and PPI dendrimers.
    Hashemi M; Tabatabai SM; Parhiz H; Milanizadeh S; Amel Farzad S; Abnous K; Ramezani M
    Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():791-800. PubMed ID: 26838910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.